SCHEMBL30337474

SCHEMBL30337474

c1cnc(-c2cc3ccccc3[nH]2)nc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITK Q08881 4/20 0.57
RAB9A P51151 4/20 0.57
NPC1 O15118 3/20 0.57
GSK3B P49841 1/20 0.56
CYP19A1 P11511 1/20 0.54
KDM4E B2RXH2 4/20 0.50
MAPT P10636 4/20 0.50
MEN1 O00255 3/20 0.50
ALDH1A1 P00352 3/20 0.50
HPGD P15428 3/20 0.50
KMT2A Q03164 3/20 0.50
CASP3 P42574 2/20 0.50
SENP8 Q96LD8 2/20 0.50
SENP7 Q9BQF6 2/20 0.50
SENP6 Q9GZR1 2/20 0.50
CHEK1 O14757 1/20 0.50
KDR P35968 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2489128 1.00 ITK (0.57) ITKRAB9ANPC1GSK3BCYP19A1
SCHEMBL28221040 0.85 RAB9A (0.53) ITKRAB9ANPC1GSK3BCYP19A1
SCHEMBL28399450 0.83 RAB9A (0.61) ITKRAB9ANPC1GSK3BCYP19A1
SCHEMBL4778165 0.81 GSK3B (0.50) ITKRAB9ANPC1GSK3BCYP19A1
SCHEMBL308319 0.81 GSK3B (0.61) ITKRAB9ANPC1GSK3BCYP19A1
SCHEMBL29470995 0.81 GSK3B (0.61) ITKRAB9ANPC1GSK3BCYP19A1
SCHEMBL29631691 0.80 RAB9A (0.74) ITKRAB9ANPC1GSK3BCYP19A1
SCHEMBL374022 0.80 RAB9A (0.74) ITKRAB9ANPC1GSK3BCYP19A1
SCHEMBL5179280 0.80 ITK (0.61) ITKRAB9ANPC1GSK3BCYP19A1
SCHEMBL4780727 0.79 RIPK1 (0.59) ITKRAB9ANPC1GSK3BCYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115974845-B Preparation method of Ornitinib intermediate 奥锐特药业股份有限公司 2024-09-20 CN disclosed
CN-115974845-A Preparation method of oxitinib intermediate 奥锐特药业股份有限公司 2023-04-18 CN disclosed